OptiLight by Lumenis
The First and Only IPL FDA Approved for Dry Eye Management
Optilight IPL (Intense Pulsed Light) is an FDA-approved technology that uses pulses of light energy to treat dry eye disease. The treatment works by delivering intense pulses of light energy to the surface of the eyelid to reduce inflammation around the eyes, enabling oil-producing meibomian glands to better lubricate the eyes and significantly reduce unpleasant dry eye symptoms.
Meibomian gland dysfunction (MGD) is a common cause of dry eye, which is characterized by blockages in the Meibomian glands. These glands are located in the eyelids and produce the oily layer of the tear film that helps to lubricate the eyes. When these glands become blocked, the eyes can become dry, itchy and red.
Dry eye is a common condition characterized by a lack of sufficient lubrication and moisture on the surface of the eyes, which can lead to discomfort, redness, and even vision problems. It can be caused by a variety of factors, including aging, certain medical conditions, and certain medications. Optilight IPL has been found to be a safe and effective treatment for dry eye, helping to improve symptoms such as burning, itching, and redness.
In dry eye, Optilight IPL treatment is typically administered to the lower eyelid area. During the treatment, the light energy is delivered to the skin and underlying tissue, stimulating the production of new blood vessels and increasing blood flow to the area. This can help to improve the health of the skin, making it better able to retain moisture and provide lubrication to the eyes.
Overall, Optilight IPL is a non-invasive treatment that can provide significant benefits for people with dry eye. It is a safe, quick and effective treatment that can be used to improve symptoms such as discomfort, redness and dryness. Additionally, it can also help to improve the overall appearance of the skin around the eyes and may be used in combination with other treatment options to improve the symptoms of dry eye.
Schedule Your IPL Dry Eye Consultation Today
(410) 291-1718
The Dermamed Quadra Q4 IPL for Drye Eye Syndrome
The Dermamed Quadra Q4 with DES (Dry Eye Syndrome) is a medical-grade Intense Pulsed Light technology specifically designed by innovator Dr. Rolando Toyos, MD, medical director and founder of the Toyos Clinic in Memphis, TN.
After many years of research supported by a grant from the American Society of Cataract and Refractive Surgery, Dr. Toyos refined this new approach for dry eye treatment, related to meibomian gland dysfunction, and the results have been exceptional. Rapid, powerful bursts of light at specific wavelengths causes changes in blood vessels adjacent to the surface of the skin, increase the skin temperature and eliminates problematic flora on the skin and eyes, all of which have beneficial effects on meibomian gland dysfunction.
Prior to the Dermamed Quadra Q4 with DES IPL device, the existing technologies and IPL devices were inconsistent, and the bulb’s intensity would diminish over time. Dr. Toyos worked to solve these problems. “Now, we have an instrument that’s safe, with reproducible results,” he says. (Dr. Toyos emphasizes that doctors should not attempt this using just any IPL equipment.)
The first effect of the IPL dry eye treatment is the immediate heat, which acts like “the best hot compress.” The light is absorbed into the skin generating heat that melts down the thick secretions obstructing the gland opening. After the IPL treatment, the glands are expressed removing the festered secretions. Giving most patients relief right away.
Research has also uncovered several other relevant effects of IPL dry eye treatment. Closing off the blood vessels near the surface of the skin decreases inflammatory cytokines that contribute to meibomian gland dysfunction. Evidence also suggests that IPL decreases and kills parasites on the eyelash margin (Demadex) that can cause meibomian gland problems.
Blepharitis
Lid Disease
The IPL dry eye treatment help with blepharitis by reducing inflammation such as facial and/or ocular rosacea and telangiectasia.
Meibomian Gland Dysfunction (MGD)
OptiLight IPL is a light-based treatment that uses precise, intense broad spectrum light to address signs of dry eye disease due to meibomian gland dysfunction (MGD). MGD is the most common cause of dry eye disease, accounting for about 86% of cases. The treatment addresses inflammation, which is one of the key underlying factors in MG
Demodex
Mites
IPL dry eye treatment reduces the load of demodex mites and bacteria around the eyes that stimulate infection.
Ocular Rosacea
Telangiectasia
The IPL dry eye treatment help with blepharitis by reducing inflammation such as facial and/or ocular rosacea and telangiectasia.